UBS Group set a €89.00 ($103.49) target price on Symrise (FRA:SY1) in a research report report published on Thursday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
SY1 has been the subject of a number of other research reports. Morgan Stanley increased their target price on shares of Wynn Resorts from $130.00 to $135.00 and gave the company an equal weight rating in a research report on Friday, May 10th. Baader Bank set a €53.00 ($61.63) target price on shares of Compugroup Medical and gave the company a neutral rating in a research report on Tuesday, April 30th. Kepler Capital Markets reiterated a buy rating and issued a $134.00 target price on shares of Airbus in a research report on Tuesday, April 30th. JPMorgan Chase & Co. increased their target price on shares of Weight Watchers International from $12.00 to $14.00 and gave the company an underweight rating in a research report on Tuesday, April 30th. Finally, Sanford C. Bernstein initiated coverage on shares of Beigene in a research report on Tuesday, June 4th. They issued an outperform rating and a $201.00 target price for the company. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have issued a buy rating to the company. The company currently has an average rating of Hold and an average price target of €79.30 ($92.21).
Shares of SY1 opened at €82.84 ($96.33) on Thursday. The firm has a 50-day moving average of €85.64. Symrise has a 52-week low of €56.96 ($66.23) and a 52-week high of €73.48 ($85.44).
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Featured Story: Yield Curve
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.